Download

Download Full Text (9.4 MB)

Contents

  • Immunotherapy for Smoldering Myeloma: Clinical trials test PD-1, DC38 inhibitors to delay progression from premalignant disease to multiple myeloma.
  • Malignant Pheochromocytoma and Sympathetic Paraganglioma Research: Studies may expand treatment options for patients with rare neuroendocrine tumors.
  • Hypofractionated Partial-Breast Irradiation: Clinical trial tests 10-day external-beam radiation therapy regimen after lumpectomy for patients with early-stage breast cancer.
  • HOUSE CALL: Support for Cancer Patients: Patients, caregivers find many types of support from various organizations

Publication Date

8-1-2017

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Manasanch, Elisabet; Jimenez, Camilo; Jessop, Aaron; Habra, Mouhammed; Hyde, Samuel; Graham, Paul; Smith, Benjamin; Bloom, Elizabeth; Schultz, Debbie; Thames, Howard D.; Smoldering Multiple Myeloma; Multiple Myeloma; Clinical Trials as Topic; Antineoplastic Agents; Pheochromocytoma; Paraganglioma; Biomedical Research; Neuroendocrine Tumors; Genetic Testing; Breast Neoplasms; Mastectomy, Segmental; Radiotherapy; Radiation Dose Hypofractionation; Patients.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Redacted

OncoLog, Volume 62, Number 08, August 2017

Share

COinS